Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

School ratings in early-onset depression.

Mattison RE.

J Am Acad Child Adolesc Psychiatry. 2012 Jun;51(6):653-4. doi: 10.1016/j.jaac.2012.03.004. No abstract available.

PMID:
22632626
2.

Summer is the best time for Treatment of Resistant Depression in Adolescents (TORDIA): the importance of school in medication trials.

Bostic JQ.

J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1095-7. doi: 10.1016/j.jaac.2011.08.010. No abstract available.

PMID:
22023997
3.

Does cognitive-behavioral therapy response in youth with obsessive-compulsive disorder differ if treatment ends during summer?

Arnold EB, De Nadai AS, Lewin AB, Geffken GR, Reid A, McNamara JP, Storch EA.

Ann Clin Psychiatry. 2014 Nov;26(4):299-300. No abstract available.

4.

Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break.

Shamseddeen W, Clarke G, Wagner KD, Ryan ND, Birmaher B, Emslie G, Asarnow JR, Porta G, Mayes T, Keller MB, Brent DA.

J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1140-8. doi: 10.1016/j.jaac.2011.07.022. Epub 2011 Sep 9.

5.

Saving lives: can we predict and prevent adolescent suicide?

Weder N.

J Am Acad Child Adolesc Psychiatry. 2012 Apr;51(4):339-40. doi: 10.1016/j.jaac.2012.01.014. No abstract available.

PMID:
22449635
6.

Joy returns last: anhedonia and treatment resistance in depressed adolescents.

Rubin DH.

J Am Acad Child Adolesc Psychiatry. 2012 Apr;51(4):353-5. doi: 10.1016/j.jaac.2012.01.012. No abstract available.

PMID:
22449641
7.

Serotonin toxicity in a CYP2D6 poor metabolizer, initially diagnosed as a drug-resistant major depression.

Gressier F, Ellul P, Dutech C, Ait Tayeb Ael K, Monfort J, Corruble E, Becquemont L, Hardy P, Verstuyft C.

Am J Psychiatry. 2014 Aug;171(8):890. doi: 10.1176/appi.ajp.2014.13101377. No abstract available.

PMID:
25082493
8.

Venlafaxine and treatment-resistant depression.

Thase ME, Friedman ES, Howland RH.

Depress Anxiety. 2000;12 Suppl 1:55-62. Review.

PMID:
11098415
9.

Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.

Lee SH, Choi TK, Lee E, Seok JH, Lee SH, Lee HS, Kim SJ.

Neuropsychobiology. 2010 Aug;62(3):198-206. doi: 10.1159/000319362. Epub 2010 Jul 22.

11.

Dosing by side effect threshold: two cases of panic disorder responsive to low-dose venlafaxine.

Orenstein H, Raskind MA.

J Clin Psychiatry. 2010 Jan;71(1):89-91. doi: 10.4088/JCP.09l05016blu. No abstract available.

PMID:
20129010
12.

Venlafaxine-induced excessive yawning.

Chen CH, Lu ML.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):156-7. doi: 10.1016/j.pnpbp.2008.10.014. Epub 2008 Oct 31. No abstract available.

PMID:
19000733
13.

Reduced testosterone level in a venlafaxine treated patient.

Bell S, Shipman M.

Ann Clin Psychiatry. 2000 Sep;12(3):171-3.

PMID:
10984008
14.

Treatment of obsessive-compulsive disorder with venlafaxine.

Grossman R, Hollander E.

Am J Psychiatry. 1996 Apr;153(4):576-7. No abstract available.

PMID:
8599411
15.

Reboxetine adjunct for partial or nonresponders to antidepressant treatment.

Rubio G, San L, López-Muñoz F, Alamo C.

J Affect Disord. 2004 Jul;81(1):67-72.

PMID:
15183602
16.

Venlafaxine versus SSRI therapy for major depression. Results of comparative efficacy trials.

Bakish D.

Postgrad Med. 1999 Nov;106(6 Suppl):24-30. doi: 10.3810/pgm.11.1999.suppl1.4.

PMID:
19667501
17.

Medication-associated somnambulism.

Lange CL.

J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):211-2. No abstract available.

PMID:
15725964
18.

Long-term treatment of geropsychiatric depressed patients with venlafaxine.

Amore M, Ricci M, Zanardi R, Perez J, Ferrari G.

J Affect Disord. 1997 Dec;46(3):293-6.

PMID:
9547127
19.

Efficacy of venlafaxine in the treatment of severe depression.

Kienke AS, Rosenbaum JF.

Depress Anxiety. 2000;12 Suppl 1:50-4. Review.

PMID:
11098414
20.

Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.

Papadimitriou GN, Theleritis CG, Papageorgiou CC, Kalogeromitros D, Syrigou E, Gregoriou S, Rabavilas AD.

J Eur Acad Dermatol Venereol. 2006 Sep;20(8):1019. No abstract available.

PMID:
16922966

Supplemental Content

Support Center